Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
1(8%)
Results Posted
9%(1 trials)

Phase Distribution

Ph early_phase_1
1
8%
Ph not_applicable
11
85%
Ph phase_1
1
8%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
1(7.7%)
N/ANon-phased studies
11(84.6%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(11)
Other(1)

Detailed Status

Completed11
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (7.7%)
Phase 11 (7.7%)
N/A11 (84.6%)

Trials by Status

completed1185%
recruiting18%
unknown18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
OTHER
Total Trials
13